Orchard Therapeutics PLC (NASDAQ:ORTX)

1.24
Delayed Data
As of Jan 14
 -0.02 / -1.59%
Today’s Change
1.15
Today|||52-Week Range
9.08
-6.06%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Orchard Therapeutics PLC have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 6.50. The median estimate represents a +625.81% increase from the last price of 1.24.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Orchard Therapeutics PLC. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.27
Sales
$300.0K
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.03%
 
 
 
 
 
 
Growthannually 25.90%
 
 
 
 
 

Sales

Growthquarterly -74.83%
 
 
 
 
 
 
Growthannually -33.01%
 
 
 
 
 
Key to the earnings and sales forecast charts.